Do Low-Risk Prostate Cancer Patients Choosing Surveillance Attend Enough Checkups?

A study in Cancer in December 2015 found most men with low-risk prostate cancer choosing close surveillance were not followed sufficiently, risking progression. Although among men’s commonest and deadliest cancers, prostate cancer has highly successful outcomes with correct treatment.
Options include surgery, radiotherapy and close surveillance without intervention.
Close surveillancemeans no intervention unless disease progresses, with regular checkups. Studies show survival similar to surgery and radiotherapy in low-risk and some intermediate-risk disease. Avoiding their possible side effects makes surveillance advantageous and increasingly popular.
A recent American study, however, reported that most choosing surveillance were not followed closely enough, posing progression risk.
Also featured on the American Society of Clinical Oncology website, the study reviewed men diagnosed during 2004-2007, approximately 38,000 men, and assessed adherence in about 3,600 under surveillance. Recommended criteria included routine PSA measurements, regular physical examination and prostate biopsy at least every 2 years. Only 4,5% (166 men) adhered.
Close surveillance for low-risk prostate cancer is advantageous for survival and side effects. This study certainly does not mean it should be avoided; it is increasingly preferred in America and other medically advanced countries. The lesson is to consider carefully whether required follow-up can be ensured before choosing surveillance, then perform it without interruption.
Sources
Population-based assessment of determining predictors for quality of prostate cancer surveillance.
Cancer. 2015;121:4150-7
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.